Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

Multiple Sclerosis

Volumn 12, Issue 6, 2006, Pages 814-823

  Saccardi, Ricardo ^a   Kozak, T ^b   Bocelli Tyndall, C ^c   Fassas, A ^d   Kazis, A ^d   Havrdova, E ^b   Carreras, E ^e   Saiz, A ^e   Lowenberg B ^f   te Boekhorst, P A W ^f   Gualandi, F ^g   Openshaw, H ^h   Longo, G ^a   Pagliai, F ^a   Massaceci, L ^a   Deconink, E ⁱ   Ouyang, J ^j   Nagore, F J Z ^k   Besalduch, J ^l   Lisukov, I A ^m   Bonini, A ⁿ   Merelli, E ^o   Slavin, S ^p   Gratwohl, A ^c   Passweg, J ^c   Tyndall, A ^c   Steck, A J ^c   Andolina, M ^q   Capobianco, M ^r   Martin, J L D ^s   Lugaresi, A ^t   Meucci, G ^u   Saez R A ^v   Clark, R E ^w   Fernandez, M N ^x   Fouillard, L ^y   Herstenstein, B ^z   Koza, V ^aa   Cocco, E ^ab   Baurmann, H ^ac   Mancardi, G L ^g   more..

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d G PAPANICOLAOU HOSPITAL   (Greece)

^e HOSPITAL CLÍNIC   (Spain)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF GENOA   (Italy)

^h CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^j THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^m INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

ⁿ S MARIA NUOVA HOSPITAL   (Italy)

^o UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^p HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^q INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^r Nephrology Unit   (Italy)

^s HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^t UNIVERSITY OF CHIETI   (Italy)

^u UNIVERSITY HOSPITAL OF PISA   (Italy)

^v HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^w ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^x HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^y HÔPITAL SAINT ANTOINE   (France)

^z HANNOVER MEDICAL SCHOOL   (Germany)

^aa CHARLES UNIVERSITY   (Czech Republic)

^ab Binaghi Hospital   (Italy)

^ac Neurologie und Klinische Neurophysiologie   (Germany)

more..

Author keywords

Autoimmune diseases; Immunosuppression; Multiple sclerosis; Stem cells transplantation; Treatment safety

Indexed keywords

AZATHIOPRINE; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GLATIRAMER; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INTERFERON; MELPHALAN; METHOTREXATE; MITOXANTRONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; DATA BASE; DISEASE COURSE; DISEASE SEVERITY; DRUG FATALITY; DRUG HYPERSENSITIVITY; ENGRAFTMENT SYNDROME; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROENTERITIS; HEALTH SURVEY; HERPES SIMPLEX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE SCLEROSIS; PNEUMONIA; RETROSPECTIVE STUDY; SAFETY; SEPSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; URINARY TRACT INFECTION; VEIN OCCLUSION;

ADOLESCENT; ADULT; DATABASES, FACTUAL; DISABILITY EVALUATION; DISEASE PROGRESSION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33846297365     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506071301     Document Type: Article

References (29)

1. Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 2005; 128: 432-59.
2. Marmont AM. Stern cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases. J Rheumatol Suppl 1997; 48: 13-18.
3. Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P et al. Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant 1999; 24: 729-34.
4. Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 2005; 141: 1-9.
5. Burt RK, Fassas A, Snowden J, van Laar JM, Kozak T, Wulffraat NM et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28: 1-12.
6. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805-16.
7. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435: 620-27.
8. Edan G, Morrissey S, Le Page E. Rationale for the use of mitoxantrone in multiple sclerosis. J Neurol Sci 2004; 223: 35-39.
9. Hartung HP, Gonsette R, Konig N, Kwiecinski H, Guseo A, Morrissey SP et al. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 2002; 360: 2018-25.
10. Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M et al. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant 2004; 34: 877-81.
11. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997; 20: 631-38.
12. Burt RK, Traynor A.E, Cohen B, Karlin KH, Davis FA, Stefoski D et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 1998; 21: 537-41.
13. Kozak T, Havrdova E, Pit'ha J, Gregora E, Pytlik R, Maaloufova J et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000; 25: 525-31.
14. Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 2000; 6: 563-75.
15. Mancardi GL, Saccardi R, Filippi M, Gualandi F, Murialdo A, Inglese M et al. Autologous hematopoietic stem cell transplantation suppresses Gdenhanced MRI activity in MS. Neurology 2001; 57: 62-68.
16. Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003; 102: 2364-72.
17. Saiz A, Blanco Y, Carreras E, Berenguer J, Rovira M, Pujol T et al. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology 2004; 62: 282-84.
18. Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601-607.
19. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997; 36: 390-92.
20. Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249: 1088-97.
21. Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Y et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003; 102: 2373-78.
22. Carreras E, Saiz A, Marin P, Martinez C, Rovira M, Villamor N et al. CD34 + selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306-14.
23. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V et al. Autologous stem cell transplantation in progressive multiple sclerosis - an interim analysis of efficacy. J Clin Immunol 2000; 20: 24-30.
24. Blanco Y, Saiz A, Carreras E, Graus F. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis. Lancet Neurol 2005; 4: 54-63.
25. Frassoni F, Labopin M, Powles R, Mary JV, Arcese W, Bacigalupo A et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000; 355: 1393-98.
26. Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW et al. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a national institute of allergy and infectious diseases and national cancer institute-sponsored international workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant 2005; 11: 862-70.
27. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35: 869-79.
28. Mancardi GL, Murialdo A, Rossi P, Gualandi F, Martino G, Marmont A et al. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler 2005; 11: 367-71.
29. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.